Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fangmei Li

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Aging|November 16, 2020
CD138<sup>-</sup> multiple myeloma cells express high level of CHK1 which correlated to overall survival in MM patientDong Wu, Peihua Zhang, Fangmei Li, et al.
Zhonghua Yi Xue Za Zhi|April 16, 2002
[Expression of TTF-1 in thyroid tumors originating from follicular epithelium and its correlation with expression of RET, galectin-3 and mucin-1 genes]Yun Chen, Minghua Zhu, Xiaojun Zhou, et al.
DNA and Cell Biology|December 11, 2023
Circular RNA circXPO1 Promotes Multiple Myeloma Progression by Regulating miR-495-3p/DNA Damage-Induced Transcription 4 AxisFangmei Li, Jing Liu, Jiyu Miao, et al.
Frontiers in Oncology|August 9, 2021
PSMB7 Is a Key Gene Involved in the Development of Multiple Myeloma and Resistance to BortezomibDong Wu, Jiyu Miao, Jinsong Hu, et al.
Life Sciences|December 24, 2022
Corrigendum to "IGF-1 promotes multiple myeloma progression through PI3K/Akt-mediated epithelial-mesenchymal transition" [Life Sci. (2020) May 15;249:117503/PMID: 32142767]Yue Peng, Fangmei Li, Peihua Zhang, et al.
Life Sciences|March 7, 2020
IGF-1 promotes multiple myeloma progression through PI3K/Akt-mediated epithelial-mesenchymal transitionYue Peng, Fangmei Li, Peihua Zhang, et al.
Acta Haematologica|December 8, 2021
Using Circ-ANAPC7 as a Novel Type of Biomarker in the Monitoring of Acute Myeloid LeukemiaYing Shen, Yachun Jia, Ru Zhang, et al.
Translational Oncology|December 11, 2024
Composition analysis and mechanism of Guizhi Fuling capsule in anti-cisplatin-resistant ovarian cancerLei Dou, Yan Yan, Enting Lu, et al.
International Immunopharmacology|September 4, 2024
Immunological roles for resistin and related adipokines in obesity-associated tumorsJingxin Zhang, Enting Lu, Lei Deng, et al.
Journal of Cancer Research and Clinical Oncology|May 7, 2024
KIF22 promotes multiple myeloma progression by regulating the CDC25C/CDK1/cyclinB1 pathwayMeng Zhai, Jiyu Miao, Ru Zhang, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Aging|November 16, 2020
CD138<sup>-</sup> multiple myeloma cells express high level of CHK1 which correlated to overall survival in MM patientDong Wu, Peihua Zhang, Fangmei Li, et al.
Zhonghua Yi Xue Za Zhi|April 16, 2002
[Expression of TTF-1 in thyroid tumors originating from follicular epithelium and its correlation with expression of RET, galectin-3 and mucin-1 genes]Yun Chen, Minghua Zhu, Xiaojun Zhou, et al.
DNA and Cell Biology|December 11, 2023
Circular RNA circXPO1 Promotes Multiple Myeloma Progression by Regulating miR-495-3p/DNA Damage-Induced Transcription 4 AxisFangmei Li, Jing Liu, Jiyu Miao, et al.
Frontiers in Oncology|August 9, 2021
PSMB7 Is a Key Gene Involved in the Development of Multiple Myeloma and Resistance to BortezomibDong Wu, Jiyu Miao, Jinsong Hu, et al.
Life Sciences|December 24, 2022
Corrigendum to "IGF-1 promotes multiple myeloma progression through PI3K/Akt-mediated epithelial-mesenchymal transition" [Life Sci. (2020) May 15;249:117503/PMID: 32142767]Yue Peng, Fangmei Li, Peihua Zhang, et al.
Life Sciences|March 7, 2020
IGF-1 promotes multiple myeloma progression through PI3K/Akt-mediated epithelial-mesenchymal transitionYue Peng, Fangmei Li, Peihua Zhang, et al.
Acta Haematologica|December 8, 2021
Using Circ-ANAPC7 as a Novel Type of Biomarker in the Monitoring of Acute Myeloid LeukemiaYing Shen, Yachun Jia, Ru Zhang, et al.
Translational Oncology|December 11, 2024
Composition analysis and mechanism of Guizhi Fuling capsule in anti-cisplatin-resistant ovarian cancerLei Dou, Yan Yan, Enting Lu, et al.
International Immunopharmacology|September 4, 2024
Immunological roles for resistin and related adipokines in obesity-associated tumorsJingxin Zhang, Enting Lu, Lei Deng, et al.
Journal of Cancer Research and Clinical Oncology|May 7, 2024
KIF22 promotes multiple myeloma progression by regulating the CDC25C/CDK1/cyclinB1 pathwayMeng Zhai, Jiyu Miao, Ru Zhang, et al.
Pageof 3